Hims & Hers Health, Inc. ($HIMS) shares increased over 40% following the announcement that Novo Nordisk ($NOVO) will distribute its weight-loss drugs through the Hims & Hers platform.

Mar 9, 2026, 3:32:26 PM UTC(3 hours ago)

Impact: High

Affected Assets

Hims & Hers Health, Inc. ($HIMS) shares increased over 40% following the announcement that Novo Nordisk ($NOVO) will distribute its weight-loss drugs through the Hims & Hers platform.
Hims & Hers Health ($HIMS) shares surged over 40% following an agreement with Novo Nordisk ($NOVO).
Novo Nordisk will distribute its weight-loss drugs through the Hims & Hers platform.
The agreement resolves a patent infringement lawsuit filed by Novo Nordisk against Hims & Hers.
Hims & Hers will cease advertising compounded GLP-1 drugs.
The deal follows a prior, short-lived partnership and a subsequent lawsuit between the companies.

Sources

$HIMS surges more than 40% on news that $NOVO will distribute its weight-loss drugs through the platform. https://t.co/H5mTRNboCe

Download Our App

Stay up-to-date with the market and manage your portfolio on the go

Know More

Hims & Hers Health, Inc. ($HIMS) shares increased over 40% following the announcement that Novo Nordisk ($NOVO) will distribute its weight-loss drugs through the Hims & Hers platform. | Foxly Invest